Le Lézard
Classified in: Health
Subject: MRR

Skincare Supplement Market to Reach US$ 4,500 Million by 2034 Amid Rising Shift toward Organic Ingredients from Chemical-laden Gels and Creams | Future Market Insights, Inc.


The market is expected to grow at a significant CAGR over the forecast period, due to the increasing social media marketing initiatives manufacturers and providers undertake to promote these products globally. Asia Pacific region will lead the global skin care supplement market during the forecast period 2024 to 2034.

NEWARK, Del. , May 8, 2024 /PRNewswire/ -- The global skincare supplement market size is projected to reach US$ 2,780 million in 2024. It is estimated to attain a valuation of around US$ 4,500 million by 2034. The industry is set to witness a CAGR of 8.8% in the forecast period 2024 to 2034.

Future Market Insights Global & Consulting Pvt. Ltd. Logo

Functionalities such as skin de-aging, wounds & marks healing, skin brightening, skin hydrating, and acne reduction have captured the demand for effective skincare products and are driving growth. The shift of consumers toward natural and organic alternatives of harmful skincare creams and gels, as well as rising awareness among consumers regarding preventive healthcare, are principal factors for a strong growth rate.

Request a Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-19584

Research & development investments are also a key factor in the growth of the market, as advancements in experimenting and analyzing various formulae have led to the rise of effective supplements sourced from natural ingredients. Out-of-the-box marketing techniques such as regularizing skincare supplements among the masses and reaching out to aging populations around the world point to significant growth for the skincare supplement industry.

Key Takeaways from the Global Skincare Supplement Market Study:

"Increasing use of social media platforms like Snapchat and Instagram is compelling individuals to move toward natural supplements to bolster their skin's appearance and prevent issues like acne. Hence, leading players are launching unique formulations to attract a large consumer base," says a lead analyst at Future Market Insights (FMI).

Who is Winning?

Only a new product with exceptional functionality and competitive price can become successful, as the skincare supplement market is a consumer-driven one, with price and effectiveness playing significant roles in the adoption of a product. Companies able to create such products and distribute them effectively to a specific consumer base hold the potential for share expansion.

Some of these leaders of the global skincare supplement market include Amway, HUM Nutrition Inc, Nestle, Meiji Holdings Co Ltd, Shiseido Co Ltd, Unilever, Johnson & Johnson, Perricone MD, and Vitabiotics Ltd. For instance,

Request Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-19584

Key Segments of Market Report

By Functionality:

Few of the leading functionalities include skin de-aging, skin hydration, acne reduction, wound and mark healing, and skin brightening.

By Form:

In terms of form, the industry is segregated into tablets/pills, capsules, liquid, powder, gummies/chewables, and others.

By Sales Channel:

Hypermarkets/supermarkets, specialty stores, e-commerce, drug stores and pharmacies, health and wellness stores, convenience stores, and departmental stores.

By Region:

Information about key countries across South Asia, East Asia, Oceania, North America, Latin America, Europe, and the Middle East and Africa is provided.

Get Valuable Insights into the Global Skincare Supplement Market

Future Market Insights, in its new offering, provides a thorough, detailed, and unbiased analysis of the global skincare supplement market, presenting historical demand data for the years 2019 to 2023 and forecast statistics for the years 2024 to 2034. The study categorizes valuable insights on the global skincare supplement market based on functionality, form, sales channel, and regions.

Buy Now: https://www.futuremarketinsights.com/checkout/19584

About the Food & Beverage Division at Future Market Insights:

Expert analysis, actionable insights, and strategic recommendations ? the food & beverage team at Future Market Insights helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and one million+ data points, the team has analyzed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Explore FMI's related Coverage on Healthcare Market Insights Domain:

Dietary Supplement Market: Intensified R&D in infant nutrition and breast milk alternatives is poised to fuel the dietary supplement market, driving a 9.5% CAGR between 2024 and 2034.

Probiotic Supplement Market: FMI predicts an 11.2% CAGR for probiotic supplements due to growing awareness of preventive healthcare. Market to reach $23,874.5 Million by 2034.

Digestive Health Supplements Market: The global digestive health supplements market is expected to reach US$17,160 million in 2023, with a projected 6% CAGR, reaching US$29,648.6 million over the forecast period.

Multi Nutritional Supplement Market: Multi Nutritional Supplement Market is expected to advance at a 5.9% CAGR from 2022 to 2032, comprehensive Report by Future Market Insights.

Postnatal Health Supplements Market: Postnatal Health Supplement Market is expected to hit US$ 2.7 billion at CAGR of 7.2% during forecast period 2023 to 2033 | Data by Future Market Insights, Inc.

Green Supplement Market: Green Supplement Market to reach US$ 563.3 Million in 2022. Demand for green supplements is projected at a CAGR of 3.8 %, reaching around USD 818.0 Million by 2032.

Protein Supplement Market: Global Protein Supplement Market is projected to surpass US$ 62.9 billion, growing at 8.5% CAGR from forecast period 2023 to 2033.

Postbiotic Supplements Market: Postbiotic Supplements Market is estimated to be valued at US$ 10.8 million in 2024 & grow at a CAGR of 10.90%, totaling a valuation of US$ 30.5 million by 2034.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
[email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

 

SOURCE Future Market Insights


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: